Indivior's Mark Crossley to Participate in Jefferies 2018 Global Healthcare Conference on June 5th

Thursday, May 24, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

SLOUGH, England, May 24, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that Mark

Crossley, CFO, will participate in Jefferies 2018 Global Healthcare Conference on Tuesday, June 5th, 2018, at 8:30 a.m. local time, in New York City.
Crossley will discuss Indivior's business and outlook. His remarks will be webcast live and the broadcast will be available on the "Investors" section of Indivior's website (www.indivior.com). If you plan on listening to the live webcast please allow sufficient time to register and download any audio software required to access the discussion.

About Indivior Indivior is a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy and health policy while providing education on evidence-based treatment models that have revolutionized modern addiction treatment. The name is the fusion of the words individual and endeavour, and the tagline "Focus on you" makes the Company's commitment clear. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a strong pipeline of product candidates designed to both expand on its heritage in this category and address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder and schizophrenia. Headquartered in the United States in Richmond, VA, Indivior employs more than 1000 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more.

Cision View original content:http://www.prnewswire.com/news-releases/indiviors-mark-crossley-to-participate-in-jefferies-2018-global-healthcare-conference-on-june-5th-300654387.html

SOURCE Indivior PLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store